Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma × Immunotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 37 Lung Neoplasms 14 Melanoma 13 Neoplasm Metastasis 12 Esophageal Neoplasms 10 Carcinoma, Hepatocellular 10 Breast Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Esophageal Squamous Cell Carcinoma 6 Rectal Neoplasms 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Stomach Neoplasms 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Recurrence 3 Neoplasms 3 Multiple Myeloma 3 Cholangiocarcinoma 3 Carcinoma, Renal Cell 3 Small Cell Lung Carcinoma 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasm, Residual 2 Nasopharyngeal Carcinoma 2 Locally Advanced Non-small Cell Lung Cancer 2

Interventions

Cyclophosphamide 272 Rituximab 243 Etoposide 136 Filgrastim 128 fludarabine phosphate 105 Cytarabine 98 Vincristine 97 Radiotherapy 96 Melphalan 95 Doxorubicin 90 Peripheral Blood Stem Cell Transplantation 82 Methotrexate 80 fludarabine 78 Prednisone 78 Busulfan 77 Tacrolimus 54 Whole-Body Irradiation 52 Mycophenolic Acid 52 Granulocyte Colony-Stimulating Factor 52 Dexamethasone 52 Antilymphocyte Serum 51 Carmustine 49 Cyclosporine 39 Lenalidomide 38 Methylprednisolone 37 Bortezomib 37 Bendamustine Hydrochloride 34 sargramostim 33 Stem Cell Transplantation 31 Ifosfamide 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06202885 2024-01-12

CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy

Seoul St. Mary's Hospital

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡